CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Control - Conventional SCS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03110601
NCT03110601N/ACompleted

Trialing of PM Modulation Therapy in Patients With Chronic Intractable Low Back Pain With or Without Leg Pain

Stimgenics LLC·interventional·Posted Apr 12, 2017·Updated Apr 16, 2019

In Brief

A clinical study evaluating Control - Conventional SCS and Test - Stimgenics SCS for Chronic Pain. Completed, enrolled 25 participants across 1 site.

Detailed Summary

Trialing of PM modulation therapy in patients with chronic intractable low back pain

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 12, 2017
Enrollment StartMay 5, 2017
Primary CompletionOct 12, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.2 years ago

Interventions

Control - Conventional SCSdevice

Conventional SCS Parameters

Test - Stimgenics SCSdevice

Stimgenics SCS Parameters